A096530 Stock Overview
Manufactures and sells molecular diagnostics products worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Seegene, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩21,100.00 |
52 Week High | ₩30,600.00 |
52 Week Low | ₩19,040.00 |
Beta | -1.12 |
11 Month Change | -0.24% |
3 Month Change | -8.46% |
1 Year Change | 1.69% |
33 Year Change | -73.26% |
5 Year Change | 64.84% |
Change since IPO | 401.58% |
Recent News & Updates
Recent updates
A Look At The Fair Value Of Seegene, Inc. (KOSDAQ:096530)
Mar 07Is Seegene, Inc. (KOSDAQ:096530) Trading At A 32% Discount?
May 06I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease
Mar 15Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?
Feb 25Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?
Feb 08What Is The Ownership Structure Like For Seegene, Inc. (KOSDAQ:096530)?
Jan 22Calculating The Fair Value Of Seegene, Inc. (KOSDAQ:096530)
Jan 07Declining Stock and Solid Fundamentals: Is The Market Wrong About Seegene, Inc. (KOSDAQ:096530)?
Dec 23Can You Imagine How Elated Seegene's (KOSDAQ:096530) Shareholders Feel About Its 656% Share Price Gain?
Dec 08I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease
Nov 24Shareholder Returns
A096530 | KR Biotechs | KR Market | |
---|---|---|---|
7D | 3.2% | 1.6% | 1.3% |
1Y | 1.7% | 22.2% | 5.8% |
Return vs Industry: A096530 underperformed the KR Biotechs industry which returned 17.7% over the past year.
Return vs Market: A096530 underperformed the KR Market which returned 7.2% over the past year.
Price Volatility
A096530 volatility | |
---|---|
A096530 Average Weekly Movement | 3.7% |
Biotechs Industry Average Movement | 7.8% |
Market Average Movement | 5.0% |
10% most volatile stocks in KR Market | 11.1% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A096530 has not had significant price volatility in the past 3 months.
Volatility Over Time: A096530's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 1,008 | Jong-Yoon Chun | www.seegene.com |
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes.
Seegene, Inc. Fundamentals Summary
A096530 fundamental statistics | |
---|---|
Market cap | ₩973.32b |
Earnings (TTM) | -₩3.46b |
Revenue (TTM) | ₩367.27b |
2.7x
P/S Ratio-281.2x
P/E RatioIs A096530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A096530 income statement (TTM) | |
---|---|
Revenue | ₩367.27b |
Cost of Revenue | ₩152.48b |
Gross Profit | ₩214.79b |
Other Expenses | ₩218.26b |
Earnings | -₩3.46b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -75.04 |
Gross Margin | 58.48% |
Net Profit Margin | -0.94% |
Debt/Equity Ratio | 7.5% |
How did A096530 perform over the long term?
See historical performance and comparison